Organigram Holdings Inc. announced on November 1, 2025, the launch of Edison Sonics gummies, its inaugural product utilizing the company's proprietary FAST™ nanoemulsion technology. This represents a first-to-market innovation for Organigram.
The FAST™ technology has been clinically validated to deliver up to 50% faster onset and nearly double the cannabinoid concentrations at peak effect compared to traditional edibles. This technological advancement aims to provide a superior consumer experience.
This product launch is a significant milestone in Organigram's innovation strategy, leveraging its collaboration with British American Tobacco. The enhanced efficacy and rapid onset of Edison Sonics gummies are expected to differentiate them in the competitive edibles market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.